SCWorx Receives Nasdaq Hearings Panel Decision Granting the Company’s Request to Continue its Listing on the Nasdaq Stock Market, Subject to Compliance Conditions
Summary
SCWorx received Nasdaq Hearings Panel approval to remain listed, but only if it meets a set of compliance deadlines. The company must secure shareholder approval for a reverse split, execute the split, and then trade at or above $1.00 for 20 straight sessions. If it misses those deadlines, Nasdaq will delist the stock and trading will remain on OTC Markets. SCWorx says it will keep working on its healthcare supply chain data platform and customer and partner relationships while it completes the compliance plan.
AskAI Classifications
Sectors
HealthTech
Logistics and Supply Chain
General Healthcare software
Functions
ERP and Process Management
Business Intelligence and Analytics
ERP Software
Linked Companies
SCWorx
$1M to $5M